LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA – Gilead Sciences, Inc. Transaction History
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA portfolio value:
$1.07M
portfolio value
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA quarter portfolio value change:
-0.19%
quarter
Gilead Sciences, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -0.56% | -98 shares | -8K | $61.69 | 17.42K |
Q2 2022 | share | Decrease | -18.46% | -3.96K shares | -195K | $61.81 | 17.52K |
Q1 2022 | share | Increase | +23.34% | 4.06K shares | 13K | $59.45 | 21.49K |
Q4 2021 | share | Increase | +3.86% | 648 shares | 93K | $73.36 | 17.42K |
Q3 2021 | share | Increase | +2.04% | 335 shares | 40K | $69.85 | 16.78K |
Q2 2021 | share | Increase | +3.19% | 508 shares | 102K | $68.17 | 16.44K |
Q1 2021 | share | Decrease | -4.04% | -671 shares | 62K | $63.33 | 15.93K |
Q4 2020 | share | Decrease | -2.46% | -419 shares | -108K | $56.43 | 16.60K |
Q3 2020 | share | Increase | +2.71% | 450 shares | -199K | $60.52 | 17.02K |
Q2 2020 | share | Increase | +56.06% | 5.95K shares | 481K | $72.94 | 16.57K |
Q1 2020 | share | Decrease | -11.64% | -1.39K shares | 13K | $70.22 | 10.62K |
Q4 2019 | share | Decrease | -4.79% | -605 shares | -19K | $60.43 | 12.02K |
Q3 2019 | share | Increase | +6.57% | 778 shares | 0 | $58.4 | 12.62K |
Q2 2019 | share | Increase | +2.89% | 333 shares | 51K | $61.67 | 11.84K |
Q1 2019 | share | Decrease | -6.34% | -780 shares | -20K | $58.79 | 11.51K |
Q4 2018 | share | Decrease | -69.78% | -28.38K shares | -2.37M | $56.02 | 12.29K |
Q3 2018 | share | Decrease | -77.92% | -143.52K shares | -9.90M | $68.57 | 40.68K |
Q2 2018 | share | Decrease | -50.93% | -191.19K shares | -15.25M | $62.43 | 184.20K |
Q1 2018 | share | Decrease | -12.78% | -54.99K shares | -2.53M | $65.91 | 375.40K |
Q4 2017 | share | Decrease | -11.69% | -56.99K shares | -8.65M | $62.19 | 430.39K |
Q3 2017 | share | Decrease | -3.04% | -15.28K shares | 1.24M | $69.84 | 487.39K |
Q2 2017 | share | Decrease | -18.05% | -110.73K shares | -3.41M | $60.63 | 502.68K |
Q1 2017 | share | Decrease | -14.19% | -101.43K shares | -9.52M | $57.72 | 613.42K |
Q4 2016 | share | Decrease | -3.76% | -27.95K shares | -7.58M | $60.39 | 714.85K |
Q3 2016 | share | Increase | +13.05% | 85.73K shares | 3.95M | $66.31 | 742.81K |
Q2 2016 | share | Increase | +0.63% | 4.14K shares | -5.16M | $69.49 | 657.07K |
Q1 2016 | share | Increase | +4.57% | 28.53K shares | -3.20M | $76.1 | 652.93K |